Casson AG[au] - Search Results

Year	Number of Results
1984	1
1986	1
1987	3
1988	1
1990	2
1991	5
1992	3
1993	4
1994	6
1995	4
1996	4
1997	4
1998	5
1999	3
2000	2
2001	1
2002	3
2003	6
2004	4
2005	9
2006	6
2007	2
2008	4
2009	11
2010	7
2011	3
2012	5
2013	2
2014	7
2015	4
2016	1
2017	1
2022	0

1

Heyde's syndrome.

Casson AG, McKenzie NN. Casson AG, et al. Chest. 1988 Oct;94(4):891-2. doi: 10.1378/chest.94.4.891. Chest. 1988. PMID: 3262491

2

Physical activity, obesity and risk for esophageal adenocarcinoma.

Balbuena L, Casson AG. Balbuena L, et al. Among authors: casson ag. Future Oncol. 2009 Sep;5(7):1051-63. doi: 10.2217/fon.09.65. Future Oncol. 2009. PMID: 19792973 Review.

3

Epidemiology and molecular biology of Barrett esophagus.

Casson AG, Williams L, Guernsey DL. Casson AG, et al. Semin Thorac Cardiovasc Surg. 2005 Winter;17(4):284-91. doi: 10.1053/j.semtcvs.2005.09.005. Semin Thorac Cardiovasc Surg. 2005. PMID: 16428034 Review.

4

Improving outcomes after esophagectomy: the impact of operative volume.

Casson AG, van Lanschot JJ. Casson AG, et al. J Surg Oncol. 2005 Dec 1;92(3):262-6. doi: 10.1002/jso.20368. J Surg Oncol. 2005. PMID: 16299792 Review.

5

Waiting for scheduled surgery: A complex patient experience.

Carr T, Teucher U, Casson AG. Carr T, et al. Among authors: casson ag. J Health Psychol. 2017 Mar;22(3):290-301. doi: 10.1177/1359105315603464. Epub 2016 Jul 10. J Health Psychol. 2017. PMID: 26349617

6

Epigenetic aberrations and targeted epigenetic therapy of esophageal cancer.

Zhao R, Casson AG. Zhao R, et al. Among authors: casson ag. Curr Cancer Drug Targets. 2008 Sep;8(6):509-21. doi: 10.2174/156800908785699306. Curr Cancer Drug Targets. 2008. PMID: 18781897 Review.

7

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS. Jankowski JA, et al. Among authors: casson ag. Am J Pathol. 1999 Apr;154(4):965-73. doi: 10.1016/S0002-9440(10)65346-1. Am J Pathol. 1999. PMID: 10233832 Free PMC article. Review.

8

Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Ford CH, Casson AG. Ford CH, et al. Among authors: casson ag. Cancer Chemother Pharmacol. 1986;17(3):197-208. doi: 10.1007/BF00256685. Cancer Chemother Pharmacol. 1986. PMID: 3527466 Review.

9

Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Wang LD, Zheng S, Zheng ZY, Casson AG. Wang LD, et al. Among authors: casson ag. World J Gastroenterol. 2003 Jun;9(6):1156-64. doi: 10.3748/wjg.v9.i6.1156. World J Gastroenterol. 2003. PMID: 12800215 Free PMC article. Review.

10

Time while waiting: patients' experiences of scheduled surgery.

Carr T, Teucher UC, Casson AG. Carr T, et al. Among authors: casson ag. Qual Health Res. 2014 Dec;24(12):1673-85. doi: 10.1177/1049732314549022. Epub 2014 Sep 5. Qual Health Res. 2014. PMID: 25192766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results